As of 2026-10-25, the EV/EBITDA ratio of Natco Pharma Ltd (NATCOPHARM.NS) is 9.83. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. NATCOPHARM.NS's latest enterprise value is 133,458.25 mil INR. NATCOPHARM.NS's TTM EBITDA according to its financial statements is 13,576.00 mil INR. Dividing these 2 quantities gives us the above NATCOPHARM.NS EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 12.1x - 28.6x | 18.9x |
| Forward P/E multiples | 14.2x - 22.9x | 18.4x |
| Fair Price | 965.39 - 2,214.53 | 1,466.56 |
| Upside | 21.9% - 179.7% | 85.2% |
| Date | EV/EBITDA |
| 2026-10-23 | 9.83 |
| 2026-10-22 | 9.75 |
| 2026-10-21 | 9.73 |
| 2026-10-19 | 9.98 |
| 2026-10-16 | 9.75 |
| 2026-10-15 | 9.74 |
| 2026-10-14 | 9.71 |
| 2026-10-13 | 9.79 |
| 2026-10-12 | 9.94 |
| 2026-10-09 | 9.81 |
| 2026-10-08 | 9.87 |
| 2026-10-07 | 10.08 |
| 2026-10-06 | 10.26 |
| 2026-10-05 | 10.23 |
| 2026-10-01 | 10.19 |
| 2026-09-30 | 10.19 |
| 2026-09-29 | 10.41 |
| 2026-09-28 | 10.22 |
| 2026-09-25 | 10.42 |
| 2026-09-24 | 10.49 |
| 2026-09-23 | 10.47 |
| 2026-09-22 | 10.15 |
| 2026-09-21 | 10.14 |
| 2026-09-18 | 10.12 |
| 2026-09-17 | 10.20 |
| 2026-09-16 | 10.15 |
| 2026-09-15 | 10.15 |
| 2026-09-11 | 10.16 |
| 2026-09-10 | 10.19 |
| 2026-09-09 | 10.28 |
| 2026-09-08 | 10.27 |
| 2026-09-07 | 10.48 |
| 2026-09-04 | 10.30 |
| 2026-09-03 | 10.44 |
| 2026-09-02 | 10.49 |
| 2026-09-01 | 10.57 |
| 2026-08-31 | 10.47 |
| 2026-08-28 | 10.68 |
| 2026-08-27 | 10.67 |
| 2026-08-26 | 10.79 |
| 2026-08-25 | 10.82 |
| 2026-08-24 | 11.01 |
| 2026-08-21 | 11.03 |
| 2026-08-20 | 10.97 |
| 2026-08-19 | 11.06 |
| 2026-08-18 | 11.26 |
| 2026-08-17 | 11.18 |
| 2026-08-14 | 11.35 |
| 2026-08-13 | 11.97 |
| 2026-08-12 | 11.48 |